ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Aspire-Lakewood Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.41−0.37 (-4.21%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Aspire-Lakewood Holdings, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | % of revenue |
|---|---|---|---|---|---|
| United States | $58.03K | $27.14K | $4.25K | $1.90K | 92.0% |
| International [Member] | $4.69K | – | – | – | 7.4% |
| Canada | $384 | $480 | – | $40 | 0.6% |
| Non-US [Member] | – | $729 | – | – | – |
From the segment and revenue-disaggregation notes of Aspire-Lakewood's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.